Secondary |
Product Used For Unknown Indication |
35.0% |
Crohn's Disease |
22.2% |
Infection |
5.1% |
Non-small Cell Lung Cancer |
3.4% |
Pain |
3.4% |
Premedication |
3.4% |
Cellulitis |
2.6% |
Keratitis Fungal |
2.6% |
Prophylaxis |
2.6% |
Rheumatoid Arthritis |
2.6% |
Antidiarrhoeal Supportive Care |
1.7% |
Blood Cholesterol |
1.7% |
Colitis Ulcerative |
1.7% |
Dental Implantation |
1.7% |
Depressed Mood |
1.7% |
Inflammatory Bowel Disease |
1.7% |
Nausea |
1.7% |
Personality Disorder |
1.7% |
Psoriasis |
1.7% |
Pyrexia |
1.7% |
|
Skin Lesion |
9.1% |
Vomiting |
9.1% |
Alanine Aminotransferase Increased |
4.5% |
Blood Cholesterol Increased |
4.5% |
Blood Electrolytes Abnormal |
4.5% |
Clostridium Difficile Colitis |
4.5% |
Crohn's Disease |
4.5% |
Dermatitis Exfoliative |
4.5% |
Endophthalmitis |
4.5% |
Infection |
4.5% |
Laryngitis |
4.5% |
Liver Injury |
4.5% |
Neutrophil Toxic Granulation Present |
4.5% |
Photosensitivity Reaction |
4.5% |
Rash |
4.5% |
Stevens-johnson Syndrome |
4.5% |
Subcutaneous Abscess |
4.5% |
Toxicity To Various Agents |
4.5% |
Tuberculosis |
4.5% |
Upper Respiratory Tract Infection |
4.5% |
|
Concomitant |
Drug Use For Unknown Indication |
14.0% |
Acne |
9.6% |
Enteritis Infectious |
9.3% |
Inflammatory Bowel Disease |
9.0% |
Asthma |
6.8% |
Vestibular Disorder |
6.2% |
Crohn's Disease |
5.9% |
Sinusitis |
5.6% |
Product Used For Unknown Indication |
5.0% |
Depression |
4.7% |
Contraception |
3.4% |
Psoriasis |
3.4% |
Epididymitis |
3.1% |
Malaria Prophylaxis |
3.1% |
Hypertension |
1.9% |
Oral Contraception |
1.9% |
Pyelonephritis |
1.9% |
Rheumatoid Arthritis |
1.9% |
Urinary Tract Infection |
1.9% |
Canavan Disease |
1.6% |
|
Vomiting |
11.8% |
Pain In Extremity |
7.9% |
Respiratory Tract Infection |
6.6% |
Ulnar Nerve Palsy |
6.6% |
Death |
5.3% |
Septic Shock |
5.3% |
Weight Increased |
5.3% |
Cellulitis |
3.9% |
Clostridial Infection |
3.9% |
Crohn's Disease |
3.9% |
Nephrolithiasis |
3.9% |
Oesophageal Ulcer |
3.9% |
Pain |
3.9% |
Periorbital Oedema |
3.9% |
Perirectal Abscess |
3.9% |
Pregnancy With Contraceptive Device |
3.9% |
Sepsis |
3.9% |
Skin Discolouration |
3.9% |
Urticaria |
3.9% |
Vaginal Haemorrhage |
3.9% |
|
Interacting |
Multiple Sclerosis |
100.0% |
|
Injection Site Swelling |
100.0% |
|